Reported relationships
Latest disclosed role at each company.
| Company | Last reported as | Report date | Published |
|---|---|---|---|
| Outset Medical, Inc.OM · Entity 7026 | Chief Financial Officer | May 15, 2025 | May 16, 2025 |
Disclosed balances
About these balances
Latest available filing per company, not a reconstructed current portfolio. Matching sequences show the last reported balance with all source rows expandable; grouping alone does not establish account ownership. Do not add unresolved positions together. Filings may omit unchanged positions, and amendments may correct only part of an older disclosure. Jointly reported shares are not necessarily this owner's personal holdings.
Outset Medical, Inc.
Report date May 15, 2025 · Filed May 16, 2025
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Common StockSEC Table I · non-derivative | Direct | 16,096 |
Reported balance
After 2025-05-15 transaction · row 1
Account or security details depend on footnotes; rows are not merged.
1 source rowRow 1 · 2025-05-15 · Sale · Disposed 584 · Balance 16,096 F1: Required number of shares sold by the reporting person to cover tax withholding obligations in connection with the vesting of an aggregate of 1,104 shares of Common Stock underlying RSUs granted to the reporting person on August 5, 2021, January 6, 2023, and January 12, 2024. This sale was made to satisfy tax withholding obligations through a "sell to cover" transaction and does not represent a discretionary trade by the reporting person. F2: These numbers have been adjusted to reflect the 1-for-15 reverse stock split the Issuer effected on March 20, 2025 (the "Reverse Stock Split"). |
Filing footnotes · ownership attribution and instrument terms
F1: Required number of shares sold by the reporting person to cover tax withholding obligations in connection with the vesting of an aggregate of 1,104 shares of Common Stock underlying RSUs granted to the reporting person on August 5, 2021, January 6, 2023, and January 12, 2024. This sale was made to satisfy tax withholding obligations through a "sell to cover" transaction and does not represent a discretionary trade by the reporting person.
F2: These numbers have been adjusted to reflect the 1-for-15 reverse stock split the Issuer effected on March 20, 2025 (the "Reverse Stock Split").
Transaction history
JSON APIPurchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”
The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.
| Transaction date | Company | Activity / security | Shares / units | Reported price | Reported value | Details |
|---|---|---|---|---|---|---|
| May 15, 2025 Filed May 16, 2025 21:20 UTC | Outset Medical, Inc. OM · Entity 7026 | SaleCommon Stock | 584 | $17.81 | $10,401.04 |
DisclosureSEC source: 0001484612-25-000045 · edgardoc.xml · nonDerivative · entry 1 Ahmed Nabeel · CIK 0001870610 · Chief Financial Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 16,096 F1 · shares: Required number of shares sold by the reporting person to cover tax withholding obligations in connection with the vesting of an aggregate of 1,104 shares of Common Stock underlying RSUs granted to the reporting person on August 5, 2021, January 6, 2023, and January 12, 2024. This sale was made to satisfy tax withholding obligations through a "sell to cover" transaction and does not represent a discretionary trade by the reporting person. F2 · balance_after: These numbers have been adjusted to reflect the 1-for-15 reverse stock split the Issuer effected on March 20, 2025 (the "Reverse Stock Split"). Read SEC document |
| February 18, 2025 Filed Feb 19, 2025 21:23 UTC | Outset Medical, Inc. OM · Entity 7026 | SaleCommon Stock | 8,659 | $0.90 | $7,793.10 |
DisclosureSEC source: 0001484612-25-000030 · edgardoc.xml · nonDerivative · entry 1 Ahmed Nabeel · CIK 0001870610 · Chief Financial Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 250,210 F1 · shares: Required number of shares sold by the reporting person to cover tax withholding obligations in connection with the vesting of an aggregate of 16,816 shares of Common Stock underlying RSUs granted to the reporting person on March 8, 2021, August 5, 2021, January 6, 2023, and January 12, 2024. This sale was made to satisfy tax withholding obligations through a "sell to cover" transaction and does not represent a discretionary trade by the reporting person. Read SEC document |
| January 21, 2025 Filed Jan 22, 2025 23:02 UTC | Outset Medical, Inc. OM · Entity 7026 | SaleCommon Stock | 3,907 | $0.80 | $3,125.60 |
DisclosureSEC source: 0001484612-25-000022 · edgardoc.xml · nonDerivative · entry 4 Ahmed Nabeel · CIK 0001870610 · Chief Financial Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 258,869 F4 · shares: Required number of shares sold by the reporting person to cover tax withholding obligations in connection with the vesting of 50% of the PSUs, described in footnote (1) above, on January 17, 2025. This sale was made to satisfy tax withholding obligations through a "sell to cover" transaction and does not represent a discretionary trade by the reporting person. Read SEC document |
| January 21, 2025 Filed Jan 22, 2025 23:02 UTC | Outset Medical, Inc. OM · Entity 7026 | SaleCommon Stock | 29,474 | $0.80 | $23,579.20 |
DisclosureSEC source: 0001484612-25-000022 · edgardoc.xml · nonDerivative · entry 3 Ahmed Nabeel · CIK 0001870610 · Chief Financial Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 262,776 F3 · shares: Required number of shares sold by the reporting person to cover tax withholding obligations in connection with 50,000 shares of Common Stock underlying PRSUs which (i) represent 50% of the target shares underlying the original award (granted on January 12, 2024, as previously reported), which were earned based on performance as of December 31, 2024, upon certification by the Compensation Committee of the Issuer's Board of Directors, and (ii) vested and were released on January 17, 2025. This sale was made to satisfy tax withholding obligations through a "sell to cover" transaction and does not represent a discretionary trade by the reporting person. Read SEC document |
| January 21, 2025 Filed Jan 22, 2025 23:02 UTC | Outset Medical, Inc. OM · Entity 7026 | SaleCommon Stock | 907 | $0.80 | $725.60 |
DisclosureSEC source: 0001484612-25-000022 · edgardoc.xml · nonDerivative · entry 2 Ahmed Nabeel · CIK 0001870610 · Chief Financial Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 292,250 F2 · shares: Required number of shares sold by the reporting person to cover tax withholding obligations in connection with 1,538 shares of Common Stock underlying PSUs which (i) were, as previously reported, granted to the reporting person on January 26, 2022, (ii) were earned as of January 26, 2024 as certified by the Compensation Committee of the Issuer's Board of Directors of the satisfaction of specified performance criteria, and (iii) vested and were released on January 17, 2025. This sale was made to satisfy tax withholding obligations through a "sell to cover" transaction and does not represent a discretionary trade by the reporting person. Read SEC document |
| January 17, 2025 Filed Jan 22, 2025 23:02 UTC | Outset Medical, Inc. OM · Entity 7026 | GrantCommon Stock | 13,256 | $0.00 | $0.00 |
DisclosureSEC source: 0001484612-25-000022 · edgardoc.xml · nonDerivative · entry 1 Ahmed Nabeel · CIK 0001870610 · Chief Financial Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 293,157 F1 · shares: On January 6, 2023, the reporting person was granted performance-based restricted stock units (PSUs) subject to the satisfaction of specified performance criteria as of December 31, 2024. The reported amount represents the number of PSUs earned by the reporting person on January 17, 2025, upon certification by the Compensation Committee of the Issuer's Board of Directors of the satisfaction of specified performance criteria. Each PSU represents a contingent right to receive a share of common stock. These PSUs vested 50% on January 17, 2025, and the remaining 50% shall vest on December 31, 2025, subject to the reporting person's continuous service through the vesting period. Read SEC document |
| January 13, 2025 Filed Jan 13, 2025 23:32 UTC | Outset Medical, Inc. OM · Entity 7026 | SaleCommon Stock | 29,031 | $0.81 | $23,515.11 |
DisclosureSEC source: 0001484612-25-000013 · edgardoc.xml · nonDerivative · entry 1 Ahmed Nabeel · CIK 0001870610 · Chief Financial Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 279,901 F1 · shares: Required number of shares sold by the reporting person to cover tax withholding obligations in connection with the vesting of an aggregate of 45,328 shares of Common Stock underlying RSUs granted to the reporting person on January 12, 2024. This sale was made to satisfy tax withholding obligations through a "sell to cover" transaction and does not represent a discretionary trade by the reporting person. Read SEC document |
| January 07, 2025 Filed Jan 8, 2025 00:24 UTC | Outset Medical, Inc. OM · Entity 7026 | SaleCommon Stock | 1,835 | $1.29 | $2,367.15 |
DisclosureSEC source: 0001484612-25-000005 · edgardoc.xml · nonDerivative · entry 1 Ahmed Nabeel · CIK 0001870610 · Chief Financial Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 308,932 F1 · shares: Required number of shares sold by the reporting person to cover tax withholding obligations in connection with 2,952 shares of Common Stock underlying PSUs which (i) were, as previously reported, originally earned by the reporting person on January 12, 2024, upon certification by the Compensation Committee of the Issuer's Board of Directors of the satisfaction of specified performance criteria, and (ii) vested and were released on January 6, 2025. This sale was made to satisfy tax withholding obligations through a "sell to cover" transaction and does not represent a discretionary trade by the reporting person. Read SEC document |
| November 15, 2024 Filed Nov 18, 2024 22:44 UTC | Outset Medical, Inc. OM · Entity 7026 | SaleCommon Stock | 4,221 | $0.80 | $3,376.80 |
DisclosureSEC source: 0001484612-24-000071 · edgardoc.xml · nonDerivative · entry 1 Ahmed Nabeel · CIK 0001870610 · Chief Financial Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 310,767 F1 · shares: Required number of shares sold by the reporting person to cover tax withholding obligations in connection with the vesting of an aggregate of 7,761 shares of Common Stock underlying RSUs granted to the reporting person on March 8, 2021, August 5, 2021, January 26, 2022, and January 6, 2023. This sale was made to satisfy tax withholding obligations through a "sell to cover" transaction and does not represent a discretionary trade by the reporting person. Read SEC document |
| August 15, 2024 Filed Aug 15, 2024 23:57 UTC | Outset Medical, Inc. OM · Entity 7026 | SaleCommon Stock | 3,971 | $0.84 | $3,335.64 |
DisclosureSEC source: 0001484612-24-000063 · edgardoc.xml · nonDerivative · entry 1 Ahmed Nabeel · CIK 0001870610 · Chief Financial Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 314,988 F1 · shares: Required number of shares sold by the reporting person to cover tax withholding obligations in connection with the vesting of an aggregate of 7,761 shares of Common Stock underlying RSUs granted to the reporting person on March 8, 2021, August 5, 2021, January 26, 2022, and January 6, 2023. This sale was made to satisfy tax withholding obligations through a "sell to cover" transaction and does not represent a discretionary trade by the reporting person. Read SEC document |
| May 16, 2024 Filed May 17, 2024 21:40 UTC | Outset Medical, Inc. OM · Entity 7026 | SaleCommon Stock | 3,918 | $3.53 | $13,830.54 |
DisclosureSEC source: 0001484612-24-000049 · edgardoc.xml · nonDerivative · entry 1 Ahmed Nabeel · CIK 0001870610 · Chief Financial Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 318,959 F1 · shares: Required number of shares sold by the reporting person to cover tax withholding obligations in connection with the vesting of an aggregate of 7,761 shares of Common Stock underlying RSUs granted to the reporting person on March 8, 2021, August 5, 2021, January 26, 2022 and January 6, 2023. This sale was made to satisfy tax withholding obligations through a "sell to cover" transaction and does not represent a discretionary trade by the reporting person. Read SEC document |
| March 01, 2024 Filed Mar 4, 2024 21:34 UTC | Outset Medical, Inc. OM · Entity 7026 | SaleCommon Stock | 1,584 | $3.15 | $4,989.60 |
DisclosureSEC source: 0001484612-24-000036 · edgardoc.xml · nonDerivative · entry 2 Ahmed Nabeel · CIK 0001870610 · Chief Financial Officer 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 322,877 F2 · kind: The sales reported in this Form 4 were effected pursuant to a Rule 10b51 Trading Plan adopted by the reporting person on February 17, 2023. Read SEC document |
| February 29, 2024 Filed Mar 4, 2024 21:34 UTC | Outset Medical, Inc. OM · Entity 7026 | OtherCommon Stock | 1,584 | $2.68 | $4,245.12 |
DisclosureSEC source: 0001484612-24-000036 · edgardoc.xml · nonDerivative · entry 1 Ahmed Nabeel · CIK 0001870610 · Chief Financial Officer 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 324,461 F1 · balance_after: Includes 1,584 shares of Common Stock acquired pursuant to the Outset Medical, Inc. 2020 Employee Stock Purchase Plan ("ESPP"), for the purchase period of September 1, 2023 to February 29, 2024. This transaction is exempt from Rule 16b-3(c). Read SEC document |
| February 23, 2024 Filed Feb 26, 2024 21:05 UTC | Outset Medical, Inc. OM · Entity 7026 | Tax withholdingCommon Stock | 10,639 | $3.72 | $39,577.08 |
DisclosureSEC source: 0001484612-24-000035 · edgardoc.xml · nonDerivative · entry 2 Ahmed Nabeel · CIK 0001870610 · Chief Financial Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 322,877 F2 · shares: Required number of shares withheld by the Issuer to cover tax withholding obligations in connection with the vesting of RSUs on February 23, 2024 described in footnote (1) above. This transaction does not represent a sale or discretionary trade by the reporting person. Read SEC document |
| February 23, 2024 Filed Feb 26, 2024 21:05 UTC | Outset Medical, Inc. OM · Entity 7026 | GrantCommon Stock | 20,922 | $0.00 | $0.00 |
DisclosureSEC source: 0001484612-24-000035 · edgardoc.xml · nonDerivative · entry 1 Ahmed Nabeel · CIK 0001870610 · Chief Financial Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 333,516 F1 · shares: Represents restricted stock units (RSUs) granted to the reporting person on February 23, 2024 in lieu of 50% of the reporting person's 2023 annual cash bonus amount at the request of the reporting person. The RSUs were fully vested on the grant date. Read SEC document |
| February 15, 2024 Filed Feb 16, 2024 22:24 UTC | Outset Medical, Inc. OM · Entity 7026 | SaleCommon Stock | 4,403 | $3.57 | $15,718.71 |
DisclosureSEC source: 0001484612-24-000027 · edgardoc.xml · nonDerivative · entry 1 Ahmed Nabeel · CIK 0001870610 · Chief Financial Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 312,594 F1 · shares: Required number of shares sold by the reporting person to cover tax withholding obligations in connection with the vesting of an aggregate of 7,766 shares of Common Stock underlying RSUs granted to the reporting person on March 8, 2021, August 5, 2021, January 26, 2022 and January 6, 2023. This sale was made to satisfy tax withholding obligations through a "sell to cover" transaction and does not represent a discretionary trade by the reporting person. Read SEC document |
| January 16, 2024 Filed Jan 18, 2024 00:59 UTC | Outset Medical, Inc. OM · Entity 7026 | SaleCommon Stock | 1,726 | $4.29 | $7,404.54 |
DisclosureSEC source: 0001484612-24-000014 · edgardoc.xml · nonDerivative · entry 4 Ahmed Nabeel · CIK 0001870610 · Chief Financial Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 316,997 F4 · shares: Required number of shares sold by the reporting person to cover tax withholding obligations in connection with the vesting of PSUs on January 12, 2024 described in footnote (3) above. This sale was made to satisfy tax withholding obligations through a "sell to cover" transaction and does not represent a discretionary trade by the reporting person. Read SEC document |
| January 12, 2024 Filed Jan 18, 2024 00:59 UTC | Outset Medical, Inc. OM · Entity 7026 | GrantCommon Stock | 5,904 | $0.00 | $0.00 |
DisclosureSEC source: 0001484612-24-000014 · edgardoc.xml · nonDerivative · entry 3 Ahmed Nabeel · CIK 0001870610 · Chief Financial Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 318,723 F3 · shares: On January 26, 2022, the reporting person was granted performance-based restricted stock units ("PSUs") subject to the satisfaction of specified performance criteria as of December 31, 2023. The reported amount represents the number of PSUs earned by the reporting person on January 12, 2024, upon certification by the Compensation Committee of the Issuer's Board of Directors of the satisfaction of specified performance criteria. Each PSU represents a contingent right to receive one share of common stock. These PSUs vested 50% on January 12, 2024, and the remaining 50% shall vest on December 31, 2024, subject to the reporting person's continuous service through the vesting date. Read SEC document |
| January 12, 2024 Filed Jan 18, 2024 00:59 UTC | Outset Medical, Inc. OM · Entity 7026 | GrantCommon Stock | 100,000 | $0.00 | $0.00 |
DisclosureSEC source: 0001484612-24-000014 · edgardoc.xml · nonDerivative · entry 2 Ahmed Nabeel · CIK 0001870610 · Chief Financial Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 312,819 F2 · shares: Represents performance-based restricted stock units ("PSUs") granted to the reporting person on January 12, 2024, that vest over a three year period based on the Issuer's common stock achieving specified prices per share, if not earlier vested upon satisfaction of specified performance criteria, subject to the reporting person's continuous service through the applicable vesting date. Each PSU represents a contingent right to receive one share of common stock. Read SEC document |
| January 12, 2024 Filed Jan 18, 2024 00:59 UTC | Outset Medical, Inc. OM · Entity 7026 | GrantCommon Stock | 136,000 | $0.00 | $0.00 |
DisclosureSEC source: 0001484612-24-000014 · edgardoc.xml · nonDerivative · entry 1 Ahmed Nabeel · CIK 0001870610 · Chief Financial Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 212,819 F1 · shares: Represents restricted stock units ("RSU") granted to the reporting person on January 12, 2024. Each RSU represents a contingent right to receive one share of common stock. These RSUs shall vest 33.33% on January 12, 2025, and the remaining 66.67% shall vest in equal installments over the course of the following two years on a quarterly basis on each February 15th, May 15th, August 15th and November 15th, subject to the reporting person's continuous service through the applicable vesting date. Read SEC document |
| January 08, 2024 Filed Jan 9, 2024 01:29 UTC | Outset Medical, Inc. OM · Entity 7026 | SaleCommon Stock | 10,709 | $5.49 | $58,792.41 |
DisclosureSEC source: 0001484612-24-000007 · edgardoc.xml · nonDerivative · entry 1 Ahmed Nabeel · CIK 0001870610 · Chief Financial Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 76,819 F1 · shares: Required number of shares sold by the reporting person to cover tax withholding obligations in connection with the vesting of 18,877 shares of Common Stock underlying RSUs granted to the reporting person on January 6, 2023. This sale was made to satisfy tax withholding obligations through a "sell to cover" transaction and does not represent a discretionary trade by the reporting person. Read SEC document |
| November 16, 2023 Filed Nov 17, 2023 21:08 UTC | Outset Medical, Inc. OM · Entity 7026 | SaleCommon Stock | 1,643 | $4.76 | $7,820.68 |
DisclosureSEC source: 0001484612-23-000085 · edgardoc.xml · nonDerivative · entry 1 Ahmed Nabeel · CIK 0001870610 · Chief Financial Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 87,528 F1 · shares: Required number of shares sold by the reporting person to cover tax withholding obligations in connection with the vesting of an aggregate of 3,043 shares of Common Stock underlying RSUs granted to the reporting person on March 8, 2021, August 5, 2021, and January 26, 2022. This sale was made to satisfy tax withholding obligations through a "sell to cover" transaction and does not represent a discretionary trade by the reporting person. Read SEC document |
| September 01, 2023 Filed Sep 5, 2023 20:04 UTC | Outset Medical, Inc. OM · Entity 7026 | SaleCommon Stock | 545 | $13.61 | $7,417.45 |
DisclosureSEC source: 0001484612-23-000074 · edgardoc.xml · nonDerivative · entry 1 Ahmed Nabeel · CIK 0001870610 · Chief Financial Officer 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 89,171 F1 · kind: The sales reported in this Form 4 were effected pursuant to a Rule 10b51 Trading Plan adopted by the reporting person on February 17, 2023. F2 · balance_after: Includes 545 shares of Common Stock acquired pursuant to the Outset Medical, Inc. 2020 Employee Stock Purchase Plan ("ESPP"), for the purchase period of March 1, 2023 to August 31, 2023. This transaction is exempt from Rule 16b-3(c). Read SEC document |
| August 16, 2023 Filed Aug 17, 2023 20:26 UTC | Outset Medical, Inc. OM · Entity 7026 | SaleCommon Stock | 1,565 | $15.10 | $23,631.50 |
DisclosureSEC source: 0001484612-23-000067 · edgardoc.xml · nonDerivative · entry 1 Ahmed Nabeel · CIK 0001870610 · Chief Financial Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 89,171 F1 · shares: Required number of shares sold by the reporting person to cover tax withholding obligations in connection with the vesting of an aggregate of 3,043 shares of Common Stock underlying RSUs granted to the reporting person on March 8, 2021, August 5, 2021, and January 26, 2022. This sale was made to satisfy tax withholding obligations through a "sell to cover" transaction and does not represent a discretionary trade by the reporting person. F2 · price: The sale price of the reporting person's shares represents the weighted average price of all shares sold by a broker on August 16, 2023 on behalf of a group of employees of the Issuer to satisfy the payment of withholding tax liability of such employees. Read SEC document |
| August 01, 2023 Filed Aug 3, 2023 20:10 UTC | Outset Medical, Inc. OM · Entity 7026 | SaleCommon Stock | 990 | $20.07 | $19,869.30 |
DisclosureSEC source: 0001484612-23-000057 · edgardoc.xml · nonDerivative · entry 1 Ahmed Nabeel · CIK 0001870610 · Chief Financial Officer 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 90,736 F1 · kind: The sales reported in this Form 4 were effected pursuant to a Rule 10b51 Trading Plan adopted by the reporting person on February 17, 2023. Read SEC document |
| July 03, 2023 Filed Jul 5, 2023 21:38 UTC | Outset Medical, Inc. OM · Entity 7026 | SaleCommon Stock | 990 | $21.70 | $21,483.00 |
DisclosureSEC source: 0001484612-23-000052 · edgardoc.xml · nonDerivative · entry 1 Ahmed Nabeel · CIK 0001870610 · Chief Financial Officer 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 91,726 F1 · kind: The sales reported in this Form 4 were effected pursuant to a Rule 10b51 Trading Plan adopted by the reporting person on February 17, 2023. Read SEC document |
| June 01, 2023 Filed Jun 1, 2023 21:31 UTC | Outset Medical, Inc. OM · Entity 7026 | SaleCommon Stock | 990 | $20.83 | $20,621.70 |
DisclosureSEC source: 0001484612-23-000049 · edgardoc.xml · nonDerivative · entry 1 Ahmed Nabeel · CIK 0001870610 · Chief Financial Officer 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 92,716 F1 · kind: The sales reported in this Form 4 were effected pursuant to a Rule 10b51 Trading Plan adopted by the reporting person on February 17, 2023. Read SEC document |
| May 16, 2023 Filed May 17, 2023 00:32 UTC | Outset Medical, Inc. OM · Entity 7026 | SaleCommon Stock | 1,532 | $19.91 | $30,502.12 |
DisclosureSEC source: 0001484612-23-000038 · edgardoc.xml · nonDerivative · entry 1 Ahmed Nabeel · CIK 0001870610 · Chief Financial Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 93,706 F1 · price: The sale price of the reporting person's shares represents the weighted average price of all shares sold by a broker on May 16, 2023 on behalf of a group of employees of the Issuer to satisfy the payment of withholding tax liability of such employees. Read SEC document |
| May 03, 2023 Filed May 5, 2023 22:16 UTC | Outset Medical, Inc. OM · Entity 7026 | SaleCommon Stock | 990 | $20.00 | $19,800.00 |
DisclosureSEC source: 0001484612-23-000034 · edgardoc.xml · nonDerivative · entry 1 Ahmed Nabeel · CIK 0001870610 · Chief Financial Officer 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 95,238 F1 · kind: The sales reported in this Form 4 were effected pursuant to a Rule 10b51 Trading Plan adopted by the reporting person on February 17, 2023. F2 · balance_after: Includes 878 shares of Common Stock acquired pursuant to the Outset Medical, Inc. 2020 Employee Stock Purchase Plan ("ESPP"), for the purchase period of September 1, 2022 to February 28, 2023. This transaction is exempt from Section 16, pursuant to Rule 16b-3(c). Read SEC document |
| February 16, 2023 Filed Feb 17, 2023 01:45 UTC | Outset Medical, Inc. OM · Entity 7026 | SaleCommon Stock | 123 | $24.36 | $2,996.28 |
DisclosureSEC source: 0001484612-23-000024 · edgardoc.xml · nonDerivative · entry 3 Ahmed Nabeel · CIK 0001870610 · Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 95,350 F3 · kind: Required number of shares sold by the reporting person to cover tax withholding obligations in connection with the vesting of 239 shares of Common Stock underlying RSUs granted to the reporting person on March 8, 2021. This sale was made to satisfy tax withholding obligations through a "sell to cover" transaction and does not represent a discretionary trade by the reporting person. Read SEC document |
| February 16, 2023 Filed Feb 17, 2023 01:45 UTC | Outset Medical, Inc. OM · Entity 7026 | SaleCommon Stock | 1,167 | $24.36 | $28,428.12 |
DisclosureSEC source: 0001484612-23-000024 · edgardoc.xml · nonDerivative · entry 2 Ahmed Nabeel · CIK 0001870610 · Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 95,473 F2 · kind: Required number of shares sold by the reporting person to cover tax withholding obligations in connection with the vesting of 2,280 shares of Common Stock underlying RSUs granted to the reporting person on January 26, 2022. This sale was made to satisfy tax withholding obligations through a "sell to cover" transaction and does not represent a discretionary trade by the reporting person. Read SEC document |
| February 16, 2023 Filed Feb 17, 2023 01:45 UTC | Outset Medical, Inc. OM · Entity 7026 | SaleCommon Stock | 269 | $24.37 | $6,555.53 |
DisclosureSEC source: 0001484612-23-000024 · edgardoc.xml · nonDerivative · entry 1 Ahmed Nabeel · CIK 0001870610 · Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 96,640 F1 · kind: Required number of shares sold by the reporting person to cover tax withholding obligations in connection with the vesting of 525 shares of Common Stock underlying RSUs granted to the reporting person on August 5, 2021. This sale was made to satisfy tax withholding obligations through a "sell to cover" transaction and does not represent a discretionary trade by the reporting person. Read SEC document |
| January 27, 2023 Filed Jan 30, 2023 21:40 UTC | Outset Medical, Inc. OM · Entity 7026 | SaleCommon Stock | 4,938 | $27.92 | $137,868.96 |
DisclosureSEC source: 0001484612-23-000010 · edgardoc.xml · nonDerivative · entry 1 Ahmed Nabeel · CIK 0001870610 · Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 96,909 F1 · kind: Required number of shares sold by the reporting person to cover tax withholding obligations in connection with the vesting of 9,116 shares of Common Stock underlying RSUs granted to the reporting person on January 26, 2022. This sale was made to satisfy tax withholding obligations through a "sell to cover" transaction and does not represent a discretionary trade by the reporting person. Read SEC document |
| January 06, 2023 Filed Jan 9, 2023 21:54 UTC | Outset Medical, Inc. OM · Entity 7026 | GrantCommon Stock | 3,185 | $0.00 | $0.00 |
DisclosureSEC source: 0001484612-23-000006 · edgardoc.xml · nonDerivative · entry 2 Ahmed Nabeel · CIK 0001870610 · Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 101,847 F2 · shares: Represents portion of stock units granted to the reporting person on January 6, 2023 that will vest on December 31, 2025, subject only to the reporting person's continuous service through the vesting date. Each stock unit represents a contingent right to receive one share of common stock. Read SEC document |
| January 06, 2023 Filed Jan 9, 2023 21:54 UTC | Outset Medical, Inc. OM · Entity 7026 | GrantCommon Stock | 56,634 | $0.00 | $0.00 |
DisclosureSEC source: 0001484612-23-000006 · edgardoc.xml · nonDerivative · entry 1 Ahmed Nabeel · CIK 0001870610 · Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 98,662 F1 · shares: Represents restricted stock units ("RSU") granted to the reporting person on January 6, 2023. Each RSU represents a contingent right to receive one share of common stock. These RSUs shall vest 33.33% on January 6, 2024, and the remaining 66.67% shall vest in equal installments over the course of the following two years on a quarterly basis on each February 15th, May 15th, August 15th and November 15th, subject to the reporting person's continuous service through the applicable vesting date. Read SEC document |
| November 16, 2022 Filed Nov 17, 2022 21:04 UTC | Outset Medical, Inc. OM · Entity 7026 | SaleCommon Stock | 264 | $19.29 | $5,092.56 |
DisclosureSEC source: 0001484612-22-000072 · edgardoc.xml · nonDerivative · entry 2 Ahmed Nabeel · CIK 0001870610 · Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 42,028 F2 · shares: Required number of shares sold by the reporting person to cover tax withholding obligations in connection with the vesting of 524 shares of Common Stock underlying RSUs granted to the reporting person on August 5, 2021. This sale was made to satisfy tax withholding obligations through a "sell to cover" transaction and does not represent a discretionary trade by the reporting person. Read SEC document |
| November 16, 2022 Filed Nov 17, 2022 21:04 UTC | Outset Medical, Inc. OM · Entity 7026 | SaleCommon Stock | 121 | $19.29 | $2,334.09 |
DisclosureSEC source: 0001484612-22-000072 · edgardoc.xml · nonDerivative · entry 1 Ahmed Nabeel · CIK 0001870610 · Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 42,292 F1 · shares: Required number of shares sold by the reporting person to cover tax withholding obligations in connection with the vesting of 239 shares of Common Stock underlying RSUs granted to the reporting person on March 8, 2021. This sale was made to satisfy tax withholding obligations through a "sell to cover" transaction and does not represent a discretionary trade by the reporting person. Read SEC document |
| September 01, 2022 Filed Sep 2, 2022 22:56 UTC | Outset Medical, Inc. OM · Entity 7026 | SaleCommon Stock | 87 | $18.05 | $1,570.35 |
DisclosureSEC source: 0001484612-22-000068 · edgardoc.xml · nonDerivative · entry 1 Ahmed Nabeel · CIK 0001870610 · Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 42,413 F1 · kind: The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 Trading Plan adopted by the reporting person on February 22, 2022. F2 · shares: Includes 87 shares of Common Stock acquired pursuant to the Outset Medical, Inc. 2020 Employee Stock Purchase Plan ("ESPP"), for the purchase period of March 1, 2022 to August 31, 2022. This transaction is exempt from Rule 16b-3(c). Read SEC document |
| August 16, 2022 Filed Aug 16, 2022 22:12 UTC | Outset Medical, Inc. OM · Entity 7026 | SaleCommon Stock | 121 | $21.48 | $2,599.08 |
DisclosureSEC source: 0001484612-22-000062 · edgardoc.xml · nonDerivative · entry 1 Ahmed Nabeel · CIK 0001870610 · Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 42,413 F1 · shares: Required number of shares sold by the reporting person to cover tax withholding obligations in connection with the vesting of 239 shares of Common Stock underlying RSUs granted to the reporting person on March 8, 2021. This sale was made to satisfy tax withholding obligations through a "sell to cover" transaction and does not represent a discretionary trade by the reporting person. Read SEC document |
| August 08, 2022 Filed Aug 9, 2022 20:01 UTC | Outset Medical, Inc. OM · Entity 7026 | SaleCommon Stock | 1,048 | $19.25 | $20,174.00 |
DisclosureSEC source: 0001484612-22-000061 · edgardoc.xml · nonDerivative · entry 1 Ahmed Nabeel · CIK 0001870610 · Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 42,534 F1 · shares: Required number of shares sold by the reporting person to cover tax withholding obligations in connection with the vesting of 2,099 shares of Common Stock underlying RSUs granted to the reporting person on August 5, 2021. This sale was made to satisfy tax withholding obligations through a "sell to cover" transaction and does not represent a discretionary trade by the reporting person. Read SEC document |
| July 19, 2022 Filed Jul 19, 2022 23:02 UTC | Outset Medical, Inc. OM · Entity 7026 | SaleCommon Stock | 787 | $16.56 | $13,032.72 |
DisclosureSEC source: 0001484612-22-000058 · edgardoc.xml · nonDerivative · entry 1 Ahmed Nabeel · CIK 0001870610 · Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 43,582 F1 · shares: Required number of shares sold by the reporting person to cover tax withholding obligations in connection with the vesting of 1,575 shares of Common Stock underlying RSUs granted to the reporting person on July 16, 2021. This sale was made to satisfy tax withholding obligations through a "sell to cover" transaction and does not represent a discretionary trade by the reporting person. Read SEC document |
| May 17, 2022 Filed May 17, 2022 23:01 UTC | Outset Medical, Inc. OM · Entity 7026 | SaleCommon Stock | 120 | $26.36 | $3,163.20 |
DisclosureSEC source: 0001484612-22-000039 · edgardoc.xml · nonDerivative · entry 1 Ahmed Nabeel · CIK 0001870610 · Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 44,369 F1 · shares: Required number of shares sold by the reporting person to cover tax withholding obligations in connection with the vesting of 239 shares of Common Stock underlying RSUs granted to the reporting person on March 8, 2021. This sale was made to satisfy tax withholding obligations through a "sell to cover" transaction and does not represent a discretionary trade by the reporting person. Read SEC document |
| May 02, 2022 Filed May 3, 2022 21:01 UTC | Outset Medical, Inc. OM · Entity 7026 | Exercise / conversionPerformance Options (right to buy) · Derivative | 200 | $0.00 Strike: $9.48 | $0.00 |
DisclosureSEC source: 0001484612-22-000037 · edgardoc.xml · derivative · entry 3 Ahmed Nabeel · CIK 0001870610 · Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 10,132 Underlying: Common Stock · 200 shares Expires 2030-05-26 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F2 · derivative.exercise_date: In March 2021, following the expiration of the lock-up period in connection with our initial public offering, the applicable performance and market-based vesting conditions were met and the shares underlying this stock option award became fully vested. Read SEC document |
| May 02, 2022 Filed May 3, 2022 21:01 UTC | Outset Medical, Inc. OM · Entity 7026 | SaleCommon Stock | 200 | $35.00 | $7,000.00 |
DisclosureSEC source: 0001484612-22-000037 · edgardoc.xml · nonDerivative · entry 2 Ahmed Nabeel · CIK 0001870610 · Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 44,489 F1 · kind: The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 Trading Plan adopted by the reporting person on February 22, 2022. Read SEC document |
| May 02, 2022 Filed May 3, 2022 21:01 UTC | Outset Medical, Inc. OM · Entity 7026 | Exercise / conversionCommon Stock | 200 | $9.48 | $1,896.00 |
DisclosureSEC source: 0001484612-22-000037 · edgardoc.xml · nonDerivative · entry 1 Ahmed Nabeel · CIK 0001870610 · Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 44,689 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| April 01, 2022 Filed Apr 4, 2022 21:16 UTC | Outset Medical, Inc. OM · Entity 7026 | Exercise / conversionPerformance Options (right to buy) · Derivative | 200 | $0.00 Strike: $9.48 | $0.00 |
DisclosureSEC source: 0001484612-22-000031 · edgardoc.xml · derivative · entry 6 Ahmed Nabeel · CIK 0001870610 · Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 10,332 Underlying: Common Stock · 200 shares Expires 2030-05-26 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F2 · derivative.exercise_date: This performance option vested on March 15, 2021, upon meeting the performance measures set forth in the Grant Agreement. Read SEC document |
| April 01, 2022 Filed Apr 4, 2022 21:16 UTC | Outset Medical, Inc. OM · Entity 7026 | Exercise / conversionPerformance Options (right to buy) · Derivative | 100 | $0.00 Strike: $9.48 | $0.00 |
DisclosureSEC source: 0001484612-22-000031 · edgardoc.xml · derivative · entry 5 Ahmed Nabeel · CIK 0001870610 · Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 10,532 Underlying: Common Stock · 100 shares Expires 2030-05-26 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F2 · derivative.exercise_date: This performance option vested on March 15, 2021, upon meeting the performance measures set forth in the Grant Agreement. Read SEC document |
| April 01, 2022 Filed Apr 4, 2022 21:16 UTC | Outset Medical, Inc. OM · Entity 7026 | SaleCommon Stock | 200 | $45.19 | $9,038.00 |
DisclosureSEC source: 0001484612-22-000031 · edgardoc.xml · nonDerivative · entry 4 Ahmed Nabeel · CIK 0001870610 · Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 44,489 F1 · kind: The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 Trading Plan adopted by the reporting person on February 22, 2022. Read SEC document |
| April 01, 2022 Filed Apr 4, 2022 21:16 UTC | Outset Medical, Inc. OM · Entity 7026 | Exercise / conversionCommon Stock | 200 | $9.48 | $1,896.00 |
DisclosureSEC source: 0001484612-22-000031 · edgardoc.xml · nonDerivative · entry 3 Ahmed Nabeel · CIK 0001870610 · Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 44,689 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| April 01, 2022 Filed Apr 4, 2022 21:16 UTC | Outset Medical, Inc. OM · Entity 7026 | SaleCommon Stock | 100 | $45.19 | $4,519.00 |
DisclosureSEC source: 0001484612-22-000031 · edgardoc.xml · nonDerivative · entry 2 Ahmed Nabeel · CIK 0001870610 · Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 44,489 F1 · kind: The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 Trading Plan adopted by the reporting person on February 22, 2022. Read SEC document |
Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.